BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36284066)

  • 21. Expression of the JAK and STAT superfamilies in human meningiomas.
    Magrassi L; De-Fraja C; Conti L; Butti G; Infuso L; Govoni S; Cattaneo E
    J Neurosurg; 1999 Sep; 91(3):440-6. PubMed ID: 10470819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
    Morgan EL; Macdonald A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes.
    Tsurumi A; Zhao C; Li WX
    BMC Genomics; 2017 Sep; 18(1):718. PubMed ID: 28893190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of STAT family members by glycogen synthase kinase-3.
    Beurel E; Jope RS
    J Biol Chem; 2008 Aug; 283(32):21934-44. PubMed ID: 18550525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
    J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
    Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
    Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
    Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
    EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model.
    Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH
    Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947
    [No Abstract]   [Full Text] [Related]  

  • 31. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
    Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
    J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stats: multifaceted regulators of transcription.
    Brierley MM; Fish EN
    J Interferon Cytokine Res; 2005 Dec; 25(12):733-44. PubMed ID: 16375601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.
    Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
    J Anat; 2001 May; 198(Pt 5):581-9. PubMed ID: 11430697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT Signaling in Glioma Cells.
    Swiatek-Machado K; Kaminska B
    Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses.
    McGregor G; Irving AJ; Harvey J
    FASEB J; 2017 Aug; 31(8):3449-3466. PubMed ID: 28461339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.
    Su L; David M
    J Biol Chem; 2000 Apr; 275(17):12661-6. PubMed ID: 10777558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
    Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
    Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.